Keryx Planning Pivotal Work For KRX-101 After Interim Analysis Jan. 6, 2005 By Aaron Lorenzo No Comments
Emisphere Accesses Cash Via Equity Deal, Revises Elan Debt Dec. 29, 2004 By Aaron Lorenzo No Comments
Emisphere Accesses Cash Via Equity Deal, Revises Elan Debt Dec. 29, 2004 By Aaron Lorenzo No Comments
Macugen Receives FDA's Broad Approval For All Wet AMD Types Dec. 21, 2004 By Aaron Lorenzo No Comments The FDA authorized the first anti-angiogenic treatment for ophthalmology, Macugen, which received approval for the treatment of neovascular (wet) age-related macular degeneration.(BioWorld Today)Read More
